Detalhe da pesquisa
1.
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.
Nature
; 623(7989): 1053-1061, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844613
2.
The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases.
Eur Radiol
; 34(2): 1146-1154, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615760
3.
Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015).
Breast Cancer Res
; 25(1): 39, 2023 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046348
4.
Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study.
Breast Cancer Res
; 24(1): 61, 2022 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096872
5.
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis.
Br J Cancer
; 126(1): 34-41, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671131
6.
A simple digital image analysis system for automated Ki67 assessment in primary breast cancer.
Histopathology
; 79(2): 200-209, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590538
7.
Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.
EBioMedicine
; 88: 104436, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708693
8.
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers.
Nat Commun
; 14(1): 4017, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419892
9.
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response.
JNCI Cancer Spectr
; 7(6)2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37788117
10.
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).
Clin Cancer Res
; 29(18): 3691-3705, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574209
11.
Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: The PPALM study.
Radiother Oncol
; 168: 130-137, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35093409
12.
Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast Cancers.
Clin Cancer Res
; 28(6): 1217-1228, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965950
13.
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
EBioMedicine
; 83: 104205, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985932
14.
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223.
Clin Genitourin Cancer
; 19(5): e299-e305, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958296
15.
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.
JAMA Oncol
; 7(9): 1291-1301, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34264305
16.
Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK - A16037).
Ther Adv Med Oncol
; 12: 1758835920975352, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33854564
17.
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.
Nat Commun
; 11(1): 2662, 2020 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32471999
18.
Identifying Biomarkers to Pair with Targeting Treatments within Triple Negative Breast Cancer for Improved Patient Stratification.
Cancers (Basel)
; 11(12)2019 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769425
19.
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.
JAMA Oncol
; 5(10): 1473-1478, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31369045
20.
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Nat Med
; 24(5): 628-637, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713086